GLP-1

AstraZeneca improves diabetes pen to maintain its market share

https://pharmaphorum.com/news/astrazeneca-improves-diabetes-pen-to-maintain-its-market-share/

Novo’s diabetes pill beats injections in head-to-head trials

https://pharmaphorum.com/news/novo-nordisks-success-with-oral-diabetes-drug/

The ‘game changers’ in diabetes: Novo and Lilly battle it out

https://pharmaphorum.com/views-and-analysis/diabetes-drugs-prevent-heart-attacks-strokes-novo-lilly-battle/

Sanofi GLP-1 finally approved in US

https://pharmaphorum.com/news/sanofi-glp-1-finally-approved-us/

Sanofi’s diabetes combo on target for showdown with Novo

https://pharmaphorum.com/news/sanofis-insulin-glp-1-diabetes-combo-target/

Close in 10 seconds

Pharmaphorum.com

Search